Zeitschrift für Gastroenterologie

---

• 5. Virushepatitis, Immunologie

V_5_01

Schröder, D; Churin, Y; Roderfeld, M; Glebe, D; Roeb, E:

Cytokeratins 8 and 18 are responsible for distribution and secretion of hepatitis B virus surface proteins

• Abstract
• HTML

V_5_02

Bohne, F; Meyer, C; Quitt, O; Dhamodaran, A; Alvarez, L; Caballero, S; Guillamet, A; Bruss, V; Moldenhauer, G; Momburg, F; Protzer, U:

Immunotherapeutic retargeting of effector cells towards HBV infected target cells using bispecific antibody constructs

• Abstract
• HTML

V_5_03

Bruns, T; Zimmermann, HW; Li, KK; Trivedi, PJ; Pachnio, A; Reynolds, G; Hubscher, S; Moss, PA; Adams, DH:

Virus Infection Of Hepatic Sinusoidal Endothelial Cells Regulates Hepatic T Cell Recruitment And Activation

• Abstract
• HTML

P_5_01

Martin, B; Bengsch, B; Nitschke, K; Thimme, R; Neumann-Haefelin, C:

A protective HLA-B*27 restricted epitope contributes to viral control in chronic HCV infection despite presence of viral escape mutations and is characterized by a unique T cell phenotype

• Abstract
• HTML

P_5_02

Busch, K; Hoh, A; Thimme, R:

Comparison of different inhibitory pathways in hepatitis B virus-specific CD8+ T cell exhaustion

• Abstract
• HTML

P_5_03

Michler, T; Russo, C; Bach, C; Zhang, K; Bauer, T; Protzer, U:

Correlation of fulminant hepatitis B and escape mutations in the 2nd loop of the HBsAg a-determinant

• Abstract
• HTML

P_5_04

Kefalakes, H; Jochum, C; Bohrer, AM; Hilgard, G; Kahraman, A; El Hindy, N; Heinemann, F; Gerken, G; Timm, J:

Decades after spontaneous HBsAg clearance the CD8+ T cell immune response is less vigorous compared to chronic hepatitis B viral infection

• Abstract
• HTML

P_5_05

Wenzel, JJ; Sichler, M; Schemmerer, M; Behrens, G; Leitzmann, MF; Jilg, W:

Decline in Hepatitis E Virus (HEV) Antibody Prevalence in Southeastern Germany, 1996 – 2011

• Abstract
• HTML

P_5_06

Giebeler, A; Neumann, U; Brandenburg, LO:

Deletion of Formyl-peptide receptors lead to an increased inflammatory response and enhanced liver injury following a bacterial induced hepatitis

• Abstract
• HTML

P_5_07

Schulze, K; Weismüller, T; Hübener, P; Zenouzi, R; Gotthardt, D; de Leuw, P; Bubenheim, M; Teufel, A; Zimmer, V; Lenzen, H; Reiter, F; Rust, C; Tharun, L; Quaas, A; Lammert, F; Galle, PR; Sarrazin, C; Manns, M; Lohse, AW; Schramm, C:

Der Simplified AIH Score – Kriterium zur Einleitung einer Immunsuppression bei Patienten mit Primär Sklerosierender Cholangitis: Ergebnisse einer deutschen Multicenter Studie

• Abstract
• HTML

P_5_08

Hermanns, NL; Cubero, FJ; Mohs, A; Ohl, K; Al Masaoudi, M; Lietdke, C; Tenbrock, K; Trautwein, C:

Die CREMα-abhängige T-Zellantwort hemmt Progression der chronischen Lebererkrankung und deren Komplikationen

• Abstract
• HTML

P_5_09

Krämer, B; Diegeler, S; Kokordelis, P; Glässner, A; Eisenhardt, M; Wolter, F; Boesecke, C; Goeser, F; Spengler, U; Rockstroh, JK; Nattermann, J:

Die HIV-assoziierte Dysregulation der NKp46 Expression auf NK Zellen könnte die Suszeptibilität für HCV und deren Verlauf beeinflussen

• Abstract
• HTML

P_5_10

Giersch, K; Homs, M; Volz, T; Allweiss, L; Lohse, AW; Buti, M; Petersen, J; Dandri, M; Lütgehetmann, M:

Different antiviral effects induced by interferon or entecavir in HDV infected human-chimeric uPA/SCID mice determined by new intrahepatic qRT-PCR assay

• Abstract
• HTML

P_5_11

Hoh, A; Schuch, A; Ni, Y; Bertoletti, A; Blum, HE; Urban, S; Thimme, R:

Dominance of cytolytic effector functions in hepatitis B virus-specific CD8+ T cell and NK cell mediated antiviral efficacy using hepatitis B virus infected hepatocytes overexpressing human sodium taurocholate cotransporting polypeptide

• Abstract
• HTML

P_5_12

Dammermann, W; Stiel, EM; Kohring, M; Schulze zur Wiesch, J; Lohse, AW; Lüth, S:

Easy and robust testing of T cell responsiveness to HBV antigens in whole blood of chronic Hepatitis B patients

• Abstract
• HTML

P_5_13

Solbach, P; Westhaus, S; Deest, M; Berg, T; Manns, MP; Sarrazin, C; Ciesek, S; Hahn, T von:

Endogenous oxidized LDL levels predict treatment response in interferon-based therapy of chronic hepatitis C

• Abstract
• HTML

P_5_14

Bissinger, AL; Fehrle, C; Werner, CR; Egetemeyr, D; Malek, NP; Berg, CP:

Epidemiologische Entwicklung und Genotypisierung von Patienten mit einer chronischer Hepatitis B in Deutschland: Hinweise für einen Rückgang des Genotyp A zu Gunsten des Genotyp D

• Abstract
• HTML

P_5_15

Dammermann, W; van der Maaden, K; Lüth, S:

Expression of myelin auto-antigens and myelin altered peptide ligands in the liver in EAE mice models

• Abstract
• HTML

P_5_16

Ingiliz, P; Rockstroh, JK; Nelson, M; Soriano, V; Arastéh, K; Guardiola, J; Bhagani, S; Mallolas, J; Tural, C; Puoti, M; Battegay, M; Jain, MK; Nunez, M; Marks, K; Kort, J; Stern, J; Vinisko, R; Manero, M; Dieterich, D:

Faldaprevir plus pegyliertes Interferon alpha-2a und Ribavirin (PR) bei Patienten mit HIV und Hepatitis C Genotyp (GT)-1 Koinfektion: End of Treatment Response (ETR) – Ergebnisse der Phase III Studie STARTVerso 4

• Abstract
• HTML

P_5_17

Kah, J; Volz, T; Lütgehetmann, M; Lohse, AW; Tiegs, G; Sass, G; Dandri, M:

Hemoxygenase-1 and its downstream product Biliverdin suppress HCV replication and provides hepatoprotective effects in humanized uPA/SCID mice

• Abstract
• HTML

P_5_18

Spitzley, S; Häussinger, D; Bode, JG:

Hepatitis C virus induced suppression of IκBζ and interference with IκBζ induced Lipocalin2 Expression

• Abstract
• HTML

P_5_19

Eisenbürger, S; Häussinger, D; Bode, JG:

Hepatitis C virus infection results in a reorganization of the expression pattern of ErbB receptor family members on its host cell

• Abstract
• HTML

P_5_20

Gröpper, C; Triller, N; Eisenbürger, S; Seifert, CR; Häussinger, D; Bode, JG:

Hepatitis C Virus modulates TNFα-induced chemokine production and enables EGF to induce chemokine production in its host cell

• Abstract
• HTML

P_5_21

Rau, M; Schmitt, J; Kudlich, T; Marin, JJG; Rodríguez Romero, M; Klinker, H; Tony, HP; Müllhaupt, B; Geier, A:

Higher frequency of peripheral CD3CXCR3 and CD4CXCR3 positive blood cells in HCV patients in context of bile acid retention

• Abstract
• HTML

P_5_22

Russo, C; Dembek, C; Geisler, F; Umgelter, A; Draenert, R; Protzer, U; Bauer, T:

HIV-1 infection impairs frequency and functionality of HBV-specific CD4 T cells in patients with chronic hepatitis B

• Abstract
• HTML

P_5_23

Lutterbeck, M; Broering, R; Kleinehr, K; Paul, A; Gerken, G; Schlaak, JF:

Human non-parenchymal liver cells produce type I and type III interferons in response to poly I:C, thereby mediating an antiviral state against HCV

• Abstract
• HTML

P_5_24

Langhans, B; Alwan, AW; Althausen, E; Krämer, B; Glässner, A; Nattermann, J; Strassburg, C; Spengler, U:

IL-8 hemmt die Suszeptibilität von CD56hochCD16negativ NK-Zellen gegenüber primären humanen hepatischen Sternzellen (HSC)

• Abstract
• HTML

P_5_25

Roos, K; Gotthardt, D; Giese, T; Schnitzler, P; Stremmel, W; Czock, D; Eisenbach, C:

Immunomonitoring of NFAT-regulated gene expression in liver allograft recipients under telaprevir based hepatitis C therapy reveals significant impact on residual gene activity

• Abstract
• HTML

P_5_26

Broering, R; Trippler, M; Real, CI; Lutterbeck, M; Kleinehr, K; Poggenpohl, L; Gerken, G; Schlaak, JF:

Interferon stimulated gene 15, a proviral factor in hepatitis C virus replication, is regulated by the Proteasome subunit alpha type-6

• Abstract
• HTML

P_5_27

Thoens, C; Berger, C; Trippler, M; Siemann, H; Lutterbeck, M; Broering, R; Schlaak, JF; Heinemann, FM; Heinold, A; Nattermann, J; Scherbaum, N; Alter, G; Timm, J:

KIR2DL3+ NKG2A- Natural Killer Cells Protect People who Inject Drugs against Productive Hepatitis C Virus Infection

• Abstract
• HTML

P_5_28

Bovensiepen, C; Sebode, M; Sospedra, M; Martin, R; Lohse, AW; Schramm, C; Herkel, J; Weiler-Normann, C:

Leberinfitrierende CD4 T Zellen bei der autoimmunen Hepatitis zeigen ein distinktes TH1 Profil

• Abstract
• HTML

P_5_29

Karimi, K; Kessler, T; Ramisch, K; Tasika, E; Arck, P; Tiegs, G:

Maternal Liver Damage Programs Offspring Allergic Inflammation in Mice

• Abstract
• HTML

P_5_30

Haxthausen, F von; Schwinge, D; Quaas, A; Huber, S; Herkel, J; Lohse, AW; Schramm, C:

Modulation von regulatorischen T Zellen im Mausmodell der Primär Sklerosierenden Cholangitis

• Abstract
• HTML

P_5_31

Hoyo-Becerra, C; Liu, ZJ; Gerken, G; Hermann, DM; Schlaak, JF:

New mouse model mimicking IFN-related depression in HCV patients

• Abstract
• HTML

P_5_32

Lang, PA; Xu, HC; Grusdat, M; Parish, I; Recher, M; Elford, A; Dhanji, S; Shaabani, N; Tran, CW; Dissanayake, D; Rahbar, R; Ghazarian, M; Brustle, A; Fine, J; Chen, P; Weaver, CT; Klose, C; Diefenbach, A; Carlyle, JR; Kaech, SM; Mak, TW; Ohashi, PS; Häussinger, D; Lang, KS:

NK cell activity promotes liver damage and chronic viral infection

• Abstract
• HTML

P_5_33

Kokordelis, P; Krämer, B; Boesecke, C; Glässner, A; Eisenhardt, M; Voigt, E; Ingiliz, P; Wolter, F; Strassburg, CP; Rockstroh, JK; Spengler, U; Nattermann, J:

Phänotypische und funktionelle Analyse von natürlichen Killer T (NKT)-Zellen bei HIV-Patienten mit einer akuten Hepatitis C

• Abstract
• HTML

P_5_34

Nischalke, HD; Lutz, P; Berger, C; Langhans, B; Hoerauf, A; Grünhage, F; Appenrodt, B; Lammert, F; Nattermann, J; Sauerbruch, T; Strassburg, CP; Spengler, U:

Polymorphsims in the farnesoid X receptor modify the risk for spontaneous bacterial peritonitis in cirrhotic patients

• Abstract
• HTML

P_5_35

Pereira, IVA; Wilson, M; Sarrazin, C; de Oliveira, CPMS; Manns, MP; Ciesek, S; Hahn, T von:

Primary but not secondary biliary acids inhibit hepatitis D virus entry into human hepatoma cells expressing the sodium-taurocholate cotransporting polypeptide

• Abstract
• HTML

P_5_36

Allweiss, L; Volz, T; Giersch, K; Petersen, J; Lohse, AW; Lütgehetmann, M; Dandri, M:

Proliferation of hepatitis B virus infected human hepatocytes in humanized mice treated with the entry inhibitor Myrcludex-B induces strong cccDNA reduction and maintenance of cccDNA-free hepatocytes

• Abstract
• HTML

P_5_37

Brunskole-Hummel, I; Zitzmann, A; Wenzel, J; Jilg, W:

Quality of HBsAg-specific immune memory: response to hepatitis-B-revaccination in adolescents 10 – 15 years after immunization in infancy

• Abstract
• HTML

P_5_38

Wiegand, SB; Bremer, B; Geipel, A; Bremer, CM; Wranke, A; Heidrich, B; Manns, MP; Wedemeyer, H; Glebe, D; Cornberg, M:

Quantification of Large, Middle and Small Hepatitis B virus (HBV) surface protein (HBsAg) fractions in patients with Hepatitis Delta

• Abstract
• HTML

P_5_39

Xu, HC; Mcllwain, DR; Pandyra, AA; Recher, M; Brenner, D; Häussinger, D; Ohashi, PS; Mak, TW; Lang, KS; Lang, PA:

Reactive oxygen species delay control of lymphocytic choriomeningitis virus

• Abstract
• HTML

P_5_40

Martin, B; Hennecke, N; Blum, HE; Kukolj, G; Böcher, WO; Thimme, R:

Restoration of Hepatitis C virus-specific CD8+ T-cell responses in patients undergoing IFN-free antiviral therapy

• Abstract
• HTML

P_5_41

Werner, JM; Serti, E; Chepa-Lotrea, X; Stoltzfus, J; Ahlenstiel, G; Feld, JJ; Liang, JT; Rotman, Y; Rehermann, B:

Ribavirin Pretreatment Improves the IFN-γ Response of Natural Killer Cells to IFN-based Therapy of Hepatitis C Virus Infection

• Abstract
• HTML

P_5_42

Sprinzl, MF; Grambihler, A; Ehrlich, A; Kittner, J; Ebert, M; Zeuzem, S; Cornberg, M; Lohmeyer, J; Tacke, F; Eisenbach, C; Geisler, F; Spengler, U; Schott, E; Galle, PR:

Safety of add on Interferon-alpha-2a in hepatitis B patients receiving effective nucleos(t)de therapy: Interim results from the German multicenter PADD-ON trial

• Abstract
• HTML

P_5_43

Matono, T; Churin, Y; Reinhard, H; Roderfeld, M; Schröder, D; Zahner, D; Glebe, D; Roeb, E:

Signaling pathways involved in carcinogenesis in a double hit mouse model of cholangiopathy and hepatitis B virus

• Abstract
• HTML

P_5_44

Graumann, F; Churin, Y; Roderfeld, M; Schröder, D; Glebe, D; Roeb, E:

Spontaner Verlust der Überexpression des großen HBV-Oberflächenproteins schützt Alb1-HBV-transgene Mäuse vor Leberschädigung

• Abstract
• HTML

P_5_45

Krebs, K; Böttinger, N; Huang, LR; Chmielewski, M; Arzberger, S; Gasteiger, G; Bohne, F; Aichler, M; Uckert, W; Abken, H; Heikenwälder, M; Knolle, P; Protzer, U:

T cells redirected by a chimeric antigen receptor efficiently control Hepatitis B Virus replication in an immunocompetent mouse model

• Abstract
• HTML

P_5_46

Oehler, N; Volz, T; Kah, J; Giersch, K; Allweiss, L; Petersen, J; Lohse, AW; Lütgehetmann, M; Heeren, J; Dandri, M:

The expression profile of bile acid and cholesterol synthesis genes are affected by the binding of Hepatitis B Virus to its cellular receptor

• Abstract
• HTML

P_5_47

Behrendt, P; Dörrbecker, J; Steinmann, E; Hügging, K; Menzel, N; Grabski, E; Rogalska-Taranta, M; Pfaender, S; Kalinke, U; Wedemeyer, H; Manns, MP; Pietschmann, T:

The impact of adipokines hormones on HCV life-cycle

• Abstract
• HTML

P_5_48

Ehlting, C; Trilling, M; Tiedje, C; Zimmermann, A; Le, VTK; Gaestel, M; Hengel, H; Häussinger, D; Bode, JG:

The MAPKAP kinase 2 controls IL-10 expression and protects from liver injury upon cytomegalovirus infection

• Abstract
• HTML

P_5_49

Maasoumy, B; Port, K; Markova, AA; Calle Serrano, B; Sollik, L; Kirschner, J; Mix, C; Manns, MP; Wedemeyer, H; Cornberg, M:

Thrombozytenzahl, Albumin und Bilirubin identifizieren Patienten mit chronischer Hepatitis C Zirrhose mit hohem Risiko für ein Therapieversagen und schwerwiegende Nebenwirkungen während einer Triple-Therapie mit Boceprevir oder Telaprevir

• Abstract
• HTML

P_5_50

Real, CI; Broering, R; Jahn-Hofmann, K; Ickenstein, L; John, M; Kleinehr, K; Driftmann, S; Kemper, T; Vornlocher, HP; Schirmbeck, R; Lu, M; Gerken, G; Schlaak, JF:

Toll-like receptor 3 activation mediates the expression of interferon and interferon stimulated genes during hepadnaviral replication in HBV-transgenic mice lacking the HBs-antigen

• Abstract
• HTML

P_5_51

Kozik, JH; Trautmann, T; Carambia, A; Eissing, L; Lohse, AW; Wiegard, C; Heeren, J; Herkel, J:

TREM1-Defizienz begünstigt die vorzeitige Klärung einer Virushepatitis im Mausmodell

• Abstract
• HTML

P_5_52

Werner, CR; Egetemeyr, DP; Lauer, UM; Malek, NP; Berg, CP:

Wirksamkeit und Sicherheit der Triple-Therapie mit Telaprevir bei 102 Patienten mit Hepatitis C, Genotyp 1: SVR 12 Daten

• Abstract
• HTML

P_5_53

Wehmeyer, MH; Schulze zur Wiesch, J; Eißing, F; Lohse, AW; Lüth, S:

Wirksamkeit und Sicherheit der Tripletherapie bei chronischer Hepatitis C Virusinfektion außerhalb kontrollierter Studien

• Abstract
• HTML